These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 30548256)
21. Antagonism of mivacurium-induced neuromuscular blockade in humans. Edrophonium dose requirements at threshold train-of-four count of 4. Kopman AF; Mallhi MU; Justo MD; Rodricks P; Neuman GG Anesthesiology; 1994 Dec; 81(6):1394-400. PubMed ID: 7992908 [TBL] [Abstract][Full Text] [Related]
22. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment. Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009 [TBL] [Abstract][Full Text] [Related]
23. [Effects of different doses of edrophonium antagonism of mivacurium-induced neuromuscular block in the presence of nitrous oxide, propofol, and alfentanil anesthesia]. Ripart J; Drolet P; Perreault L; Girard M Can J Anaesth; 1996 Apr; 43(4):368-72. PubMed ID: 8697552 [TBL] [Abstract][Full Text] [Related]
24. Effects of neostigmine or edrophonium on force of contraction when administered at a train-of-four ratio of 0.9 in anesthetized dogs. Romano M; Martin-Flores M; Sakai DM; Tseng CT; Campoy L; Gleed RD Vet Anaesth Analg; 2017 Nov; 44(6):1313-1320. PubMed ID: 29066245 [TBL] [Abstract][Full Text] [Related]
25. Neostigmine, pyridostigmine, and edrophonium as antagonists of pancuronium. Ferguson A; Egerszegi P; Bevan DR Anesthesiology; 1980 Nov; 53(5):390-4. PubMed ID: 7425377 [TBL] [Abstract][Full Text] [Related]
26. Spontaneous versus edrophonium-induced recovery from paralysis with mivacurium. Brandom BW; Taiwo OO; Woelfel SK; Schön H; Gronert BJ; Cook DR Anesth Analg; 1996 May; 82(5):999-1002. PubMed ID: 8610913 [TBL] [Abstract][Full Text] [Related]
27. Pharmacodynamics and the plasma concentration of mivacurium during spontaneous recovery and neostigmine-facilitated recovery. Lien CA; Belmont MR; Wray Roth DL; Okamoto M; Abalos A; Savarese JJ Anesthesiology; 1999 Jul; 91(1):119-26. PubMed ID: 10422936 [TBL] [Abstract][Full Text] [Related]
28. Effect of neostigmine at different levels of mivacurium-induced neuromuscular blockade. Trévien V; Lienhart A; Just B; Chandon M; Baras E; Camatte S Acta Anaesthesiol Scand Suppl; 1995; 106():66-9. PubMed ID: 8533550 [TBL] [Abstract][Full Text] [Related]
29. Neostigmine requirements for reversal of neuromuscular blockade following an infusion of mivacurium. Lessard MR; Trépanier CA; Rouillard JF Can J Anaesth; 1997 Aug; 44(8):836-42. PubMed ID: 9260011 [TBL] [Abstract][Full Text] [Related]
30. Neostigmine-based reversal of intermediate acting neuromuscular blocking agents to prevent postoperative residual paralysis: A systematic review. Tajaate N; Schreiber JU; Fuchs-Buder T; Jelting Y; Kranke P Eur J Anaesthesiol; 2018 Mar; 35(3):184-192. PubMed ID: 29189420 [TBL] [Abstract][Full Text] [Related]
31. Residual block after mivacurium with or without edrophonium reversal in adults and children. Bevan DR; Kahwaji R; Ansermino JM; Reimer E; Smith MF; O'Connor GA; Bevan JC Anesthesiology; 1996 Feb; 84(2):362-7. PubMed ID: 8602667 [TBL] [Abstract][Full Text] [Related]
32. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade. Naguib M; Abdulatif M; al-Ghamdi A Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753 [TBL] [Abstract][Full Text] [Related]
33. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block. Naguib M; Riad W Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536 [TBL] [Abstract][Full Text] [Related]
34. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine. Sacan O; White PF; Tufanogullari B; Klein K Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210 [TBL] [Abstract][Full Text] [Related]
35. Recovery characteristics after early administration of anticholinesterases during intense mivacurium-induced neuromuscular block. Abdulatif M Br J Anaesth; 1995 Jan; 74(1):20-5. PubMed ID: 7880699 [TBL] [Abstract][Full Text] [Related]
36. Antagonism of rapacuronium using edrophonium or neostigmine: pharmacodynamics and pharmacokinetics. Mills KG; Wright PM; Pollard BJ; Scott JM; Hing JP; Danjoux G; Hunter JM Br J Anaesth; 1999 Nov; 83(5):727-33. PubMed ID: 10690134 [TBL] [Abstract][Full Text] [Related]
38. Cardiovascular and autonomic nervous effects of edrophonium and atropine combinations during neuromuscular blockade antagonism in sheep. Clutton RE; Glasby MA Vet Anaesth Analg; 2008 May; 35(3):191-200. PubMed ID: 18282258 [TBL] [Abstract][Full Text] [Related]
39. Effect of antagonism of mivacurium-induced neuromuscular block on postoperative emesis in children. Watcha MF; Safavi FZ; McCulloch DA; Tan TS; White PF Anesth Analg; 1995 Apr; 80(4):713-7. PubMed ID: 7893023 [TBL] [Abstract][Full Text] [Related]
40. Antagonism of mivacurium block with edrophonium from various degrees of spontaneous recovery. Connolly FM; Mirakhur RK; Loan PB; McCoy EP; Symington M; Kumar N Br J Anaesth; 1995 Feb; 74(2):229-30. PubMed ID: 7696074 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]